| Literature DB >> 29188502 |
Joost Verhaagen1, Barbara Hobo2, Erich M E Ehlert2,3, Ruben Eggers2, Joanna A Korecka2,4, Stefan A Hoyng2,5, Callan L Attwell2, Alan R Harvey6,7, Matthew R J Mason2.
Abstract
Adeno-associated viral vectors have numerous applications in neuroscience, including the study of gene function in health and disease, targeting of light-sensitive proteins to anatomically distinct sets of neurons to manipulate neuronal activity (optogenetics), and the delivery of fluorescent protein to study anatomical connectivity in the brain. Moreover several phase I/II clinical trials for gene therapy of eye and brain diseases with adeno-associated viral vectors have shown that these vectors are well tolerated by human patients. In this chapter we describe a detailed protocol for the small scale production of recombinant adeno-associated viral vectors. This protocol can be executed by investigators with experience in cell culture and molecular biological techniques in any well-equipped molecular neurobiology laboratory. With this protocol we typically obtain research batches of 100-200 μL that range in titer from 5 × 1012 to 2 × 1013 genomic copies/mL.Entities:
Keywords: Adeno-associated viral vector; Amicon centrifugation device; Iodixanol; Production; Purification; Serotype
Mesh:
Year: 2018 PMID: 29188502 DOI: 10.1007/978-1-4939-7522-8_1
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745